1448 related articles for article (PubMed ID: 17325037)
1. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
2. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
3. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
Chen H; Yan GC; Gishizky ML
Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
[TBL] [Abstract][Full Text] [Related]
4. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of signaling pathways for insulin and insulin-like growth factor I.
Lopaczynski W
Acta Biochim Pol; 1999; 46(1):51-60. PubMed ID: 10453981
[TBL] [Abstract][Full Text] [Related]
6. Loss of insulin-like growth factor II receptor expression promotes growth in cancer by increasing intracellular signaling from both IGF-I and insulin receptors.
Osipo C; Dorman S; Frankfater A
Exp Cell Res; 2001 Apr; 264(2):388-96. PubMed ID: 11262195
[TBL] [Abstract][Full Text] [Related]
7. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
8. How distinct are the insulin and insulin-like growth factor I signalling systems?
Adamo M; Roberts CT; LeRoith D
Biofactors; 1992 Jan; 3(3):151-7. PubMed ID: 1599609
[TBL] [Abstract][Full Text] [Related]
9. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
10. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
11. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
Sun H; Tu X; Baserga R
Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of ethanol on insulin-like growth factor-I receptor signaling.
Seiler AE; Ross BN; Green JS; Rubin R
Alcohol Clin Exp Res; 2000 Feb; 24(2):140-8. PubMed ID: 10698364
[TBL] [Abstract][Full Text] [Related]
13. Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth.
Li W; Hyun T; Heller M; Yam A; Flechner L; Pierce JH; Rudikoff S
Cancer Res; 2000 Jul; 60(14):3909-15. PubMed ID: 10919668
[TBL] [Abstract][Full Text] [Related]
14. [The structural organization of binding determinants in insulin-like growth factor-I (IGF-I) molecule].
Kolychev AP
Zh Evol Biokhim Fiziol; 2010; 46(1):74-94. PubMed ID: 20297673
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
16. Hexachlorobenzene is a tumor co-carcinogen and induces alterations in insulin-growth factors signaling pathway in the rat mammary gland.
Randi AS; Cocca C; Carbone V; Nuñez M; Croci M; Gutiérrez A; Bergoc R; Kleiman de Pisarev DL
Toxicol Sci; 2006 Jan; 89(1):83-92. PubMed ID: 16237195
[TBL] [Abstract][Full Text] [Related]
17. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
18. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
19. A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
Burtrum D; Zhu Z; Lu D; Anderson DM; Prewett M; Pereira DS; Bassi R; Abdullah R; Hooper AT; Koo H; Jimenez X; Johnson D; Apblett R; Kussie P; Bohlen P; Witte L; Hicklin DJ; Ludwig DL
Cancer Res; 2003 Dec; 63(24):8912-21. PubMed ID: 14695208
[TBL] [Abstract][Full Text] [Related]
20. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
